December #140 : Cash Therapy - by Nicole Joseph

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

Precious Stone

More Than Just a Number

Dodging Danger

Northern Disclosure

Ask For It By Name

Learning Latex

Yule Love ’Em

Catch of the Month

Cash Therapy

A Wealth of Trouble

Think Inside the Box

Baby Bonus

New Resistance Fighters

African in America

Windy City Blues

Unfine China

It’s a Wrap

Hot Dates-December 2007

Wake Up, India

Survey Says...

Clean Sweep

Look Elsewhere

Yesterday Once More

A Day Without “Day Without Art”

Medicine Man

Suspicious Minds

Editor's Letter-December 2007

Mailbox-December 2007

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

Scroll down to comment on this story.

email print

December 2007

Cash Therapy

by Nicole Joseph

Money versus biology in HIV treatment effectiveness—guess which wins?

Can being poor affect the way you respond to HIV treatment? Yes, say researchers from the Harvard School of Public Health. In a recent study, they determined that a person’s socioeconomic position could influence the effectiveness of initial therapy—suggesting that the success of antiretroviral medication isn’t a strictly biological matter.

“In this study, we looked at a social factor to see if it would be a predictor [of] whether or not a patient is going to respond to treatment,” says Dr. Linda Marc, lead author of the study and now a lecturer at the Yale School of Public Health. “Poorer people have more daily hassles—for example, they might not have 50 cents to take the bus—[and] stress is known to influence the immune system.”

Since one or some combination of three traits—income, education and occupation—is generally used to define socioeconomic status, Marc’s group chose to examine the relationship between a person’s educational background and the success of antiretroviral therapy. They examined HIV-positive people who’d never taken meds before; after starting treatment, those with lower education levels reached initial regimen failure sooner than study participants who had college or graduate degrees. Current IV-drug-using subjects, as well as black participants—two groups who statistically may have lower levels of schooling—were also more likely to experience first-regimen failure than others.

Doctors and medical experts need to expand traditional biology-based research to take a closer look at the social factors affecting their patients, recommends Marc, who adds that “the findings support the development of health promotion programs focusing on psychological and behavioral aspects associated with HIV treatments.” Marc also says pharmaceutical companies should consider putting money toward these research areas—and soon.     

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (3 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Do you ever have problems sleeping?

Lean On Me

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.